Skip to main content
. Author manuscript; available in PMC: 2021 Nov 10.
Published in final edited form as: J Control Release. 2020 Jul 22;327:100–116. doi: 10.1016/j.jconrel.2020.07.034

Figure 8.

Figure 8.

(A–B) Tumor accumulation and antitumor activity of HDTA in KB tumor bearing mice. (C–D) Tumor accumulation and antitumor activity of HDTA4 and HTA3 in MDA-MB231 tumor bearing nude mice. (E) Tumor volume in in MDA-MB231 tumor bearing nude mice after HDTA4 and HTA3 treatment. (F) Schematic illustration of HDTA for oral delivery of DTX using bile acid transporter. Reproduced, with permission, from reference [152].